These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37770382)

  • 1. The repeated administration of rhIL-12 for 14 weeks in rhesus monkeys: A toxicity assessment.
    Ding H; Qin H; Wang J; Dong Y; Wang Q; Han Y
    J Appl Toxicol; 2024 Feb; 44(2):301-312. PubMed ID: 37770382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of recombinant human interleukin 12 to chronically SIVmac-infected rhesus monkeys.
    Watanabe N; Sypek JP; Mittler S; Reimann KA; Flores-Villanueva P; Voss G; Lord CI; Letvin NL
    AIDS Res Hum Retroviruses; 1998 Mar; 14(5):393-9. PubMed ID: 9546798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production.
    Leonard JP; Sherman ML; Fisher GL; Buchanan LJ; Larsen G; Atkins MB; Sosman JA; Dutcher JP; Vogelzang NJ; Ryan JL
    Blood; 1997 Oct; 90(7):2541-8. PubMed ID: 9326219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of the mono-PEGylated recombinant human interleukin-11 in cynomolgus monkeys.
    Yu KM; Lau JY; Fok M; Yeung YK; Fok SP; Zhang S; Ye P; Zhang K; Li X; Li J; Xu Q; Wong WT; Choo QL
    Toxicol Appl Pharmacol; 2018 Mar; 342():39-49. PubMed ID: 29407773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer.
    Robertson MJ; Cameron C; Atkins MB; Gordon MS; Lotze MT; Sherman ML; Ritz J
    Clin Cancer Res; 1999 Jan; 5(1):9-16. PubMed ID: 9918197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of subcutaneous injection and intravenous infusion of recombinant human interleukin-12 and recombinant human interleukin-12 combined with hepatitis B surface antigen in cynomolgus monkeys.
    Li R; Deng F; Fu Y; Zhang Y; Wan H; Zhou D; Gu J; Xu J
    Pharmacology; 2010; 85(6):319-27. PubMed ID: 20516733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques.
    Waldmann TA; Lugli E; Roederer M; Perera LP; Smedley JV; Macallister RP; Goldman CK; Bryant BR; Decker JM; Fleisher TA; Lane HC; Sneller MC; Kurlander RJ; Kleiner DE; Pletcher JM; Figg WD; Yovandich JL; Creekmore SP
    Blood; 2011 May; 117(18):4787-95. PubMed ID: 21385847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiation protection effect of rhIL-12 on monkey hematopoietic system].
    Xiong GL; Zhao Y; Xing S; Shen X; Ning XC; Lu SX; Li J; Guo LL; Hao R; Chen TC; Miao JL; He JC; Luo QL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):150-4. PubMed ID: 23484710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of recombinant human interleukin-6 on blood and immune parameters in middle-aged and old rhesus monkeys.
    Sun WH; Binkley N; Bidwell DW; Ershler WB
    Lymphokine Cytokine Res; 1993 Dec; 12(6):449-55. PubMed ID: 8123761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and toxicokinetics assessment of the mono-PEGylated recombinant human interleukin-11 in cynomolgus monkeys.
    Li X; Pang PS; Zhang S; Ru L; Yuan Z; Liu R; Choo QL; Wang Q; Song J; Xu Q; Zhang K; Yu KM; Xu Z
    Life Sci; 2020 Oct; 259():118244. PubMed ID: 32791145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.
    Conlon KC; Lugli E; Welles HC; Rosenberg SA; Fojo AT; Morris JC; Fleisher TA; Dubois SP; Perera LP; Stewart DM; Goldman CK; Bryant BR; Decker JM; Chen J; Worthy TA; Figg WD; Peer CJ; Sneller MC; Lane HC; Yovandich JL; Creekmore SP; Roederer M; Waldmann TA
    J Clin Oncol; 2015 Jan; 33(1):74-82. PubMed ID: 25403209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant human interleukin 6 (rhIL-6) in marmosets (Callithrix jacchus). 1. General toxicity and hematological changes.
    Klug S; Neubert R; Stahlmann R; Thiel R; Ryffel B; Car BD; Neubert D
    Arch Toxicol; 1994; 68(10):619-31. PubMed ID: 7857201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy.
    Lopes JE; Fisher JL; Flick HL; Wang C; Sun L; Ernstoff MS; Alvarez JC; Losey HC
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32317293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A four-week repeated study of intravenous toxicity of recombinant human interleukin-2 in Sprague-Dawley rats.
    Lee MJ; Park SH; Kim MJ; Kim HJ; Li Y; Ko KN; Kim D; Lee YH; Kim SH; Jang HS; Baik Y; Lee S; Kang JS; Kang JK
    Regul Toxicol Pharmacol; 2012 Nov; 64(2):253-62. PubMed ID: 22885075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of both humoral and cellular immune responses to HIV-1 gp120 by interleukin-12 in Rhesus macaques.
    van der Meide PH; Villinger F; Ansari AA; Groenestein RJ; de Labie MC; van den Hout YJ; Koornstra WH; Bogers WM; Heeney JL
    Vaccine; 2002 May; 20(17-18):2296-302. PubMed ID: 12009285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the toxicity and toxicokinetics of the novel potent tropomyosin receptor kinase (Trk) inhibitor LPM4870108 in rhesus monkeys.
    Duan S; Dong L; Wang B; Wei S; Gong X; Yu P; Li C; Gao Y; Ye L; Wang H; Tian J
    Regul Toxicol Pharmacol; 2021 Jun; 122():104886. PubMed ID: 33556418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recombinant human interleukin-6 administration on bone in rhesus monkeys.
    Binkley NC; Sun WH; Checovich MM; Roecker EB; Kimmel DB; Ershler WB
    Lymphokine Cytokine Res; 1994 Aug; 13(4):221-6. PubMed ID: 7999921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-escalation study of recombinant human interleukin-18 using two different schedules of administration in patients with cancer.
    Robertson MJ; Kirkwood JM; Logan TF; Koch KM; Kathman S; Kirby LC; Bell WN; Thurmond LM; Weisenbach J; Dar MM
    Clin Cancer Res; 2008 Jun; 14(11):3462-9. PubMed ID: 18519778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional effects of interleukin-1 on immune responses in rhesus monkeys.
    Friedman EM; Coe CL; Ershler WB
    Brain Behav Immun; 1994 Jun; 8(2):87-99. PubMed ID: 8081023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia.
    Cooley S; He F; Bachanova V; Vercellotti GM; DeFor TE; Curtsinger JM; Robertson P; Grzywacz B; Conlon KC; Waldmann TA; McKenna DH; Blazar BR; Weisdorf DJ; Miller JS
    Blood Adv; 2019 Jul; 3(13):1970-1980. PubMed ID: 31266741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.